Cherry,
I love your enthusiasm, but $6 represents nearly a billion dollar market cap, without sales their would have to be other reasons for such a price.
Don't get me wrong, it would be possible with the right partnership, or even with truly outstanding clinical trial data, but efficacy would have to be demonstrated, not just safety. I believe it will all come in time, but I expect that sales of our products as cosmetic/nutraceuticals is likely before Phase 2 efficacy trials have been run and reported. Of course one or more partnerships could be reported at any time.
When I look at the company's timelines, the Phase 2 Trials are spread out over the next couple years. Until something is known about these trials it is impossible to tell what the company may know at any given time. If the trials are run double blinded, like the Phase 1, they really aren't supposed to learn of the findings until the end. Their are trials that are not blinded at all, companies can see what's happening throughout the trials, but such trials aren't generally considered as credible as double blinded trials.
Their is a wild card that the company hasn't spoken about, Mediq. Some people heard that they were running trials themselves, I don't know that's the case, and if so I doubt their being run under Govt. approved protocols, but if they are being run, and if they demonstrate efficacy, the basis for selling the cream as a cosmetic would be established. I certainly don't know this is the case, but sales in the first or second quarter of next year would certainly be more likely if some results of efficacy could be seen, and before and after photos of psoriasis patients who tried the cream could be great evidence, even if not done in a proper clinical setting.
Gary
